SCHEMBL4565962

SCHEMBL4565962

Brc1nccc2ccccc12.O=C(O)CN(c1ccc2c(ccn2-c2nccc3ccccc23)c1)S(=O)(=O)c1cc(Cl)cc(Cl)c1

nearest known ligand 0.37

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
KEAP1 Q14145 10/20 0.37
NFE2L2 Q16236 10/20 0.37
PLAU P00749 1/20 0.34
ALDH1A1 P00352 1/20 0.34
F2 P00734 4/20 0.34
L3MBTL1 Q9Y468 1/20 0.33
TRPM8 Q7Z2W7 1/20 0.33
S1PR1 P21453 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13391330 0.95 KEAP1 (0.40) KEAP1NFE2L2PLAUALDH1A1F2
SCHEMBL4565542 0.93 F2 (0.36) KEAP1NFE2L2PLAUALDH1A1F2
SCHEMBL13390423 0.84 TRPM8 (0.34) KEAP1NFE2L2F2TRPM8
SCHEMBL3301228 0.82 KEAP1 (0.42) KEAP1NFE2L2ALDH1A1F2L3MBTL1
SCHEMBL13391299 0.82 F2 (0.38) KEAP1NFE2L2PLAUALDH1A1F2
SCHEMBL4434811 0.81 KEAP1 (0.38) KEAP1NFE2L2ALDH1A1F2
SCHEMBL3298487 0.81 ALDH1A1 (0.39) KEAP1NFE2L2PLAUALDH1A1F2
SCHEMBL4439674 0.80 ROCK1 (0.36) KEAP1NFE2L2PLAUALDH1A1L3MBTL1
SCHEMBL10357252 0.80 ALDH1A1 (0.39) KEAP1NFE2L2PLAUALDH1A1F2
SCHEMBL4430945 0.79 MAPT (0.42) KEAP1NFE2L2ALDH1A1F2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2121600-B1 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INT (DE) 2012-07-18 EP disclosed
EP-2121600-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS Boehringer Ingelheim International GmbH (DE) 2009-11-25 EP disclosed
WO-2008099000-A2 SUBSTITUTED ARYLSULPHONYLGLYCINES, THE PREPARATION THEREOF AND THE USE THEREOF AS PHARMACEUTICAL COMPOSITIONS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2008-08-21 WO disclosed